The Journal of Urology® Home Study Course 2012 Volume 187/188

AUA CME Requirements

Program Description and Objectives
The Journal of Urology® Home Study Course is a comprehensive learning activity developed by a team of educators, academicians and clinicians. After completing each lesson, the participantsshould be able to assess their knowledge of urology, demonstrate an increased knowledge base of urology, and apply the increased knowledge to improve quality of patient care.

Accreditation
The American Urological Association Education and Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American Urological Association Education and Research, Inc (AUAER) designates this enduring material for a maximum of 24.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Physicians
International physicians may also earn AMA PRA Category 1 Credits™ by participating in CME activities certified through American organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME). Accredited providers may designate activities for AMA PRA Category 1 Credit™ regardless of the location of the activity. A physician participating in such an activity would receive credit directly from the accredited provider. For a list of accredited providers, visit www.accme.org.

Non-physician Health Professionals
AUAER is not accredited to offer credit for non-physician health professionals. However, AUAER will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Target Audience
The Journal of Urology® Home Study Course is designed for practicing urologic physicians, American Board of Urology (ABU) candidates and/or residents.

Method of physician participation in the learning process
Two volumes of The Journal of Urology® are published annually. Each volume is comprised of 6 issues. Five clinically relevant articles are selected by the editor to be offered for CME in each issue of The Journal®. For CME credit, the participant must be enrolled in the home study course for the year; complete the CME questionnaire and submit answers online at www.AUANet.org/cmetests, answering 80% of the test questions correctly. Please complete the accompanying evaluation. Each issue is designated for a maximum of 2.0 AMA PRA Category 1 Credits™.

Estimated time to complete each lesson
2.0 hours

AUAER Disclosure Policy
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.

All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual's financial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented.

Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup
Limit content to evidence with no recommendations
Introduction of a debate format with an unbiased moderator (point-counterpoint)
Inclusion of moderated panel discussion
Publication of a parallel or rebuttal article for an article that is felt to be biased
Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
Divestiture of the relationship by faculty

Disclosures
(Individuals in control of the content. All individuals with their respective disclosures listed in this document are planners. Individual authors' disclosures are located with their articles in each issue of The Journal of Urology®.)

Editor, The Journal of Urology®

William D. Steers, MD
Hovey Dabney Professor of Urology
Chair, Department of Urology
University of Virginia Health System
Charlottesville, VA
Disclosures: Allergan: Scientific Study or Trial; National Institutes of Health: Consultant or Advisor; Food and Drug Administration: Consultant or Advisor; New England Research Institute (NERI): Consultant or Advisor

The Journal of Urology® Editorial Board

Karl-Erik Andersson, MD, PhD
Winston Salem, NC
Disclosures: Astellas, Pfizer, Novartis, Allergan, Xention, Sanofi-Aventis, ONO: Consultant or Advisor; Ferring, Lilly: Consultant or Advisor

Larry S. Baskin, MD
San Francisco, CA
Disclosures: Nothing to disclose

Arthur L. Burnett, II, MD
Baltimore, MD
Disclosures: Abbott: Consultant or Advisor; American Medical Systems: Consultant or Advisor, Scientific Study or Trial; Auxillium Inc: Consultant or Advisor, Scientific Study or Trial; Coloplast: Consultant or Advisor, Other; Endo Pharmaceuticals: Consultant or Advisor; National Institutes of Health: Investigator; PFIZER: Scientific Study or Trial, Consultant or Advisor; Reflexonic LLC: Consultant or Advisor, Scientific Study or Trial; Shionogi Pharma: Consultant or Advisor; TIMM Medical: Consultant or Advisor; Vivus: Scientific Study of Trial, Consultant or Advisor

Toby C. Chai, MD
Baltimore, MD
Disclosures: Allergan: Scientific Study or Trial; Medtronic: Consultant or Advisor; National Institutes of Health: Investigator; Pfizer: Consultant or Advisor

Joseph L. Chin, MD
London, ON, Canada
Disclosures: US HIFU: Scientific Study or Trial

George Christ, PhD
Lewisville, NC
Disclosures: Ion Channel Innovations, LLC: Board Member, Officer, Trustee; Tengion, Inc: Consultant or Advisor

Philipp Dahm, MD, MHSc
Gainesville, FL
Disclosures: Nothing to disclose

Michael J. Droller, MD
Pelham, NY
Disclosures: Elsevier Inc. (Urologic Oncology: Seminars and Original Investigations): Board Member, Officer, Trustee; Elsevier Inc. Journal of Urology, Associate Editor: Board Member, Officer, Trustee; Miscellaneous legal expert consultant: Consultant or Advisor

Deborah R. Erickson, MD
Lexington, KY
Disclosures: Trillium Therapeutics Inc.: Consultant or Advisor

Gerald H. Jordan, MD
Norfolk, VA
Disclosures: American Board of Urology: Board Member, Officer, Trustee; American Medical Systems: Meeting Participant or Lecturer, Consultant or Advisor; Auxillum: Consultant or Advisor; Auxillum Pharmaceuticals: Scientific Study or Trial, Meeting Participant or Lecturer; C&S Surgical: Other; Cooke Medical: Meeting Participant or Lecturer; Engineers and Doctors/Wallsten/PNN: Other; First Responders: Consultant or Advisor; Precision Medical Devices: Board Member, Officer, Trustee

David B. Joseph, MD
Birmingham, AL
Disclosures: Centers for Disease Control and Prevention: Investigator; Spina Bifida Foundatioin: Board Member, Officer, Trustee; Tengion: Scientific Study or Trial

John N. Krieger, MD
Seattlel, WA
Disclosures: I own a number of mutual funds that undoubtedly invest in health care companies. I have no direct knowledge of control: Investment interest

Gary E. Lemack, MD
Dallas, TX
Disclsoures: Allergan: Scientific Study or Trial, Consultant or Advisor; Astellas: Meeting Participant or Lecturer; Contura: Scientific Study or Trial; Pfizer: Investment Interest, Meeting Participant or Lecturer, Consultant or Advisor; Pneumoflex, Inc.: Consultant or Advisor

Mark S. Litwin, MD, MPH
Los Angeles, CA
Disclosures: Nothing to disclose

Jodi K. Maranchie, MD
Pittsburgh, PA
Disclosures: Nothing to disclose

Brian R. Matlaga, MD
Lutherville, MD
Disclosures: Nothing to disclose

Ajay Nehra, MD
Rochester, MN
Disclosures: Nothing to disclose

Craig S. Niederberger, MD
Chicago, IL
Disclosures: American Society for Reproductive Medicine: Other; NexHand: Board Member, Officer, Trustee

Robert D. Oates, MD
Boston, MA
Disclosures: Nothing to disclose

Dipen J. Parekh, MD
San Antonio, TX
Disclosures: Intuitive Surgical: Other

Raj S. Pruthi, MD
Chapel Hill, NC
Disclosures: GTx: Scientific Study or Trial

Michael L. Ritchey, MD
Phoenix, AZ
Disclosures: Nothing to disclose

Arthur I. Sagalowsky, MD
Dallas, TX
Disclosures: None – prior Bioniche involvement completed: Other

Anthony J. Schaeffer, MD
Chicago, IL
Disclosures: Advanstar Communications, Inc.: Consultant or Advisor; Astellas Pharma U.S.: Meeting Participant or Lecturer; Baylor Health Care System: Meeting Participant or Lecturer; Harper Global: Other; UpToDate: Other

Peter N. Schlegel, MD
New York, NY
Disclosures: American Board of Urology: Board Member, Officer, Trustee; GNYUTES, Inc: Board Member, Officer, Trustee; Theralogix: Board Member, Officer, Trustee

Joseph A. Smith, Jr., MD
Nashville, TN
Disclosures: Nothing to disclose

William D. Steers, MD
Charlottesville, VA
Disclosures: Allergan: Scientific Study or Trial; Food and Drug Administration: Consultant or Advisor; National Institutes of Health; Consultant or Advisor; New England Research Institute (NERI): Consultant or Advisor

Raju Thomas, MD
New Orleans, LA
Disclosures: AUA Annual CME Courses: Meeting Participant or Lecturer; AUA –Journal of Urology Editorial Board: Board Member, Officer, Trustee; Gulf South Lithotripsy: Board Member, Officer, Trustee; Intuitive Surgical: Meeting Participant or Lecturer; Journal of Endourology: Other; Journal of Urology: Board Member Officer, Trustee; Urology Gold Journal: Other

David P. Wood, MD
Ann Arbor, MI
Disclosures: Myriad: Consultant or Advisor; Steba Pharmaceuticals: Consultant or Advisor; Urotoday: Other

Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.

Disclaimer
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.

Evidence Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

System Requirements for Online Test
A PC-compatible computer running Windows XP, or a Macintosh computer running OS X 10.1 or later. Internet access. Adobe Acrobat Reader 9 or newer.

Release Date: issue month, 2012
Expiration Date: issue month, 2015

AUA Privacy and Confidentiality Policy
www.auanet.org/cme/onlineeduconf.cfm

Email cme@AUAnet.org or hstudy@AUAnet.org with any questions.